GE HEALTHCARE LIMITED - United Kingdom 

Ranking results:

Past rankings:

2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 12.000.000 0 1
2016 0 15.998.136 0 2
2014 0 3.148.000 393.500 1
2011 0 8.654.766 241.642 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ALZHEIMER EUROPE3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
VTT TECHNICAL RESEARCH CENTRE OF FINLAND3
IXICO TECHNOLOGIES LIMITED2
JANSSEN PHARMACEUTICA NV2
KAROLINSKA INSTITUTE2
STICHTING KATHOLIEKE UNIVERSITEIT2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
THE UNIVERSITY OF EDINBURGH2
ABBVIE DEUTSCHLAND GMBH & CO KG1
AC IMMUNE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
ANTAROS MEDICAL AB1
BAYER PHARMA1
BIOGEN IDEC LIMITED1
BIOXYDYN LIMITED1
BRUKER BIOSPIN MRI1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CHALMERS TEKNISKA HOEGSKOLA AB1
CHU HOPITAUX DE BORDEAUX1
COMPLEXIO SARL1
ELI LILLY AND COMPANY LIMITED1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
F HOFFMANNLA ROCHE1
FUNDACIO BARCELONABETA BRAIN RESEARCH CENTER1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GE HEALTHCARE FINLAND OY1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GOETEBORGS UNIVERSITET1
H LUNDBECK AS1
IFAKARA HEALTH INSTITUTE TRUST1
ITASUOMEN YLIOPISTO1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KAUNO TECHNOLOGIJOS UNIVERSITETAS1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KOBENHAVNS UNIVERSITET1
LIFE MOLECULAR IMAGING1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUNDS UNIVERSITET1
MALAWI MINISTRY OF HEALTH1
MERCK SHARP & DOHME CORP1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVARTIS PHARMA1
NOVO NORDISK1
PFIZER LIMITED1
REGION HOVEDSTADEN1
RIJKSUNIVERSITEIT GRONINGEN1
SANOFIAVENTIS DEUTSCHLAND1
SERVICIO MADRILENO DE SALUD1
STICHTING VUMC1
STICHTING VUVUMC1
TAKEDA DEVELOPMENT CENTRE EUROPE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
THE UNIVERSITY OF SHEFFIELD1
THE UNIVERSITY OF WARWICK1
THORAXKLINIK HEIDELBERG GEMEINNUTZIGE GEM1
TRULY LABS AB1
UNIVERSITA DEGLI STUDI DI PERUGIA1
UNIVERSITE DE BOURGOGNE1
UNIVERSITE DE GENEVE1
UNIVERSITEIT MAASTRICHT1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF AARHUS1
UNIVERSITY OF LEEDS1
UNIVERSITY OF MALAWI1
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA1

Constancy:

Total number of partners: 85
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 76
Frequent / Rare Partner Ratio: 0.12

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-10-01Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 AMYPADparticipant11.999.88615
2014-02-01From Patient Data to Clinical Diagnosis in Neurodegenerative Diseases PredictNDparticipant3.148.0008
2011-04-01Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIAparticipant2.996.8097
2011-02-01Enhancing Human Resources and Use of Appropriate Training for Maternal and Perinatal Survival In Sub-Saharan Africa ETATMBAparticipant2.499.9576
2011-02-01Evidence based Diagnostic and Treatment Planning Solution for Traumatic Brain Injuries TBIcareparticipant3.158.0009